What happened after people received Kisspeptin-54?
The longer form stayed in blood for more time. With repeated use, its early effect faded.
Why did researchers choose the longer form?
Kisspeptin-54 is a longer piece of protein made from fifty-four small parts. It starts the same brain steps as the short form.
The longer form stayed in blood for about half an hour. Kisspeptin-10 stayed for roughly four minutes in the human tests.
That gave doctors more time to check hormones tied to egg release, sperm growth, and testosterone. They used kisspeptin-54 in IVF and in women with missing periods.
The longer stay also had a limit. With steady or twice-daily use, later blood-hormone rises became smaller.
Kisspeptin-54 still isn't an approved treatment. I'd ask which study group shared your age, health, and reason for care.
What is Kisspeptin-54 made of?
Kisspeptin-54 is the larger form. It contains fifty-four amino acids, which are small parts joined to make a protein.
A paper gives the form a lab weight of 5857 daltons [8]. A dalton is a unit for weighing molecules; the figure helps tell forms apart but can't predict a benefit.
Scientists first called kisspeptin-54 metastin. Both words name the same long form.
A protein on brain cells takes in the long form and starts the next hormone steps. Blood breaks this larger form apart more slowly than kisspeptin-10.
That slower breakdown lets kisspeptin-54 act for more time. Ask why the old name appears in some papers.
How long did the longer form remain in blood?
Kisspeptin-54 stayed in human blood for almost thirty minutes [8]. That was nearly seven times longer than kisspeptin-10.
At matching amounts, kisspeptin-54 reached a higher blood level. It also kept the messenger tied to egg release and testosterone raised for more time [11].
The blood breaks kisspeptin-10 apart sooner. That difference in time is one reason many human studies chose the longer form.
A longer stay doesn't make kisspeptin-54 right for you. You'd ask what length of effect the researchers needed to measure.
What happened with Kisspeptin-54 in IVF and period studies?
A Phase 2 kisspeptin-54 trial followed 60 women at high risk of severe ovary swelling during IVF, while doctors watched them closely as an early check of benefit and safety. The trial was short.
Kisspeptin-54 helped eggs mature in 95%. Doctors saw no moderate cases, and none classed as severe or critical [5].
Live births reached 62% in one amount group. The trial didn't prove a better result than ordinary IVF care.
Women with missing periods also received kisspeptin-54. With a steady drip of kisspeptin-54, the egg-release hormone came in bursts about three times more often [4].
That blood change showed the gland was responding. Doctors didn't learn whether periods returned, eggs were released, or the women felt better.
The highest kisspeptin-54 amount worked less well. A 2025 nose-spray study also used kisspeptin-54, and blood tests showed a rise in men and women [6].
That short study reported no unwanted events. With frequent or high exposure, later hormone rises may become smaller [10].
Ask what happened to people after each short study ended. You can also ask whether doctors checked anything you could feel.